Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
63.84 USD | +1.19% | +7.52% | +14.13% |
06-26 | HC Wainwright Adjusts ANI Pharmaceuticals Price Target to $94 From $87, Maintains Buy Rating | MT |
06-24 | Top Midday Gainers | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.13% | 1.22B | |
+56.86% | 819B | |
-6.55% | 351B | |
+19.95% | 329B | |
+9.48% | 298B | |
+17.29% | 242B | |
+2.25% | 225B | |
+13.39% | 217B | |
+9.86% | 168B | |
-2.73% | 158B |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- Transcript : Alimera Sciences, Inc., ANI Pharmaceuticals, Inc. - M&A Call